• SPX
  • $5,981.09
  • 0.13 %
  • $7.99
  • DJI
  • $43,812.90
  • 0.19 %
  • $83.55
  • N225
  • $39,500.37
  • 0.3 %
  • $118.96
  • FTSE
  • $8,087.34
  • -0.66 %
  • -$53.40
  • IXIC
  • $19,269.26
  • -0 %
  • -$0.20
Taro Pharmaceutical Industries Ltd. (TARO) Stock Price, News & Analysis

Taro Pharmaceutical Industries Ltd. (TARO) Stock Price, News & Analysis

Currency in USD Disclaimer

NA

NA

NA

Day's range
$42.94
Day's range
$42.98
50-day range
$42
Day's range
$43.03
  • Country: IL
  • ISIN: IL0010827181
52 wk range
$32.67
Day's range
$45.76
Notice: This company has been marked as potentially delisted and may not be actively trading.


We are preparing, please wait

Analyst Ratings

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

Stock Score/grades

The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company

  • Altman Z Score 3.47
  • Piotroski Score 7.00
  • Grade Buy
  • Symbol (TARO)
  • Company Taro Pharmaceutical Industries Ltd.
  • Price $42.98
  • Changes Percentage (0.01%)
  • Change $0.01
  • Day Low $42.94
  • Day High $42.98
  • Year High $45.76

Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage form products. It offers its products for various therapeutic categories comprising allergy, analgesic, antibacterial, antibiotic, anticonvulsant, antiemetic, antifungal, anti-inflammatory, anti-cancer, antiplatelet agent, antipyretic, cardiovascular, CNS, corticosteroid, cosmetic, cough and cold, dermatology, diuretic, endocrine, gastrointestinal, laxative, narcotics, neuropathic pain, neuropsychiatric, sedative/hypnotic, and topical anti-neoplastic. The company provides its products in the form of capsule, cream, drops, emulsion, gel/gel kit, granules, injectable, lotion, oil, ointment, paste, powder/powder for solution, rectal suppository, shampoo, solution/solution for infusion, spray, suspension, syrup, tablets, toothpaste and mouthwash, topical foam, and topical solution. It distributes and sells its products directly to wholesalers, retail drug store chains, food chains, hospitals, mass merchandisers, grocery chains, and other direct purchasers and customers, as well as healthcare institutions and private pharmacies. The company was founded in 1950 and is based in Haifa, Israel. Taro Pharmaceutical Industries Ltd. is a subsidiary of Alkaloida Chemical Company Exclusive Group Ltd.

  • Last Earnings 11/05/2018
  • Ex-Dividend for 5/16 Dividend 12/10/2018
  • Dividend Payable 12/28/2018
  • Today N/A
  • Next Earnings (Estimated) 07/24/2024
  • Fiscal Year End N/A

  • Average Stock Price Target $0.00
  • High Stock Price Target $0.00
  • Low Stock Price Target $0.00
  • Potential Upside/Downside N/A
  • Consensus Rating Neutral
  • Rating Score (0-4) N/A
  • Research Coverage N/A

  • EPS (Most Recent Fiscal Year) $1.43
  • Trailing P/E Ratio 29.91
  • Forward P/E Ratio 29.91
  • P/E Growth 29.91
  • Net Income $53.87 M

Income Statement

Quarterly

Annual

Latest News of TARO

The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.

Enter your phone number to get Breaking News Updates

Stay ahead with instant updates! Enter your phone number for breaking news alerts, ensuring you're always in the know with the latest developments.


We are preparing, please wait

Portfolio Sync Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED
Portfolio Sync Solutions
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to Stocks.News!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.